院内成像人工智能研究转化为医疗器械:确保伦理与监管完整性
本文阐述了从院内人工智能(AI)研究到医疗器械开发的路径,涵盖概念化、开发、验证与监管合规等关键阶段,强调跨学科合作、伦理考量及EU MDR与EU AI Act下的合规要求,为放射科医生和医疗领导者提供将AI整合入临床实践的战略框架。
要点
- 转化路径包括需求识别、数据管理、模型训练、严格验证及部署后持续监测。
- 监管环境复杂,需遵循EU MDR认证流程及即将实施的EU AI Act额外合规要求。
- 伦理考量强调透明度、患者隐私与AI技术公平可及,跨学科合作至关重要。
核心结论
- 本文概述了将院内AI研究转化为医疗器械的战略框架,涵盖开发、验证、监管与伦理,以促进AI安全有效地整合入临床实践。
研究设计与样本
- 本文为综述性文章,未报告系统检索范围与纳入文献数量,也未涉及具体研究样本或设备参数。
临床应用与阅片要点
- 放射科医生和医疗领导者可参考此框架,在跨学科合作下,遵循EU MDR与EU AI Act要求,并重视透明度、患者隐私与公平可及等伦理原则,以将AI整合入临床实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
This manuscript delineates the pathway from in-house research on Artificial Intelligence (AI) to the development of a medical device, addressing critical phases including conceptualization, development, validation, and regulatory compliance. Key stages in the transformation process involve identifying clinical needs, data management, model training, and rigorous validation to ensure AI models are both robust and clinically relevant. Continuous post-deployment surveillance is essential to maintain performance and adapt to changes in clinical practice. The regulatory landscape is complex, encompassing stringent certification processes under the EU Medical Device Regulation (MDR) and the upcoming EU AI Act, which imposes additional compliance requirements aimed at mitigating AI-specific risks. Ethical considerations such as, emphasizing transparency, patient privacy, and equitable access to AI technologies, are paramount. The manuscript underscores the importance of interdisciplinary collaboration, between healthcare institutions and industry partners, and navigation of commercialization and market entry of AI devices. This overview provides a strategic framework for radiologists and healthcare leaders to effectively integrate AI into clinical practice, while adhering to regulatory and ethical standards, ultimately enhancing patient care and operational efficiency.
引用
- Pesapane F, Hauglid MK, Fumagalli M, et al. The translation of in-house imaging AI research into a medical device ensuring ethical and regulatory integrity. Eur J Radiol. 2024. PMID: 39612599. doi:10.1016/j.ejrad.2024.111852
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。